Exhibit 31.2

                        INTERIM SECTION 302 CERTIFICATION
                                  CERTIFICATION
I, Neil Martucci, certify that:

1.       I  have  reviewed  this quarterly report of Tetragenex Pharmaceuticals,
         Inc. on Form 10-QSB for the period ended September 30, 2007;

2.       Based  on  my  knowledge,  this  report does  not  contain  any  untrue
         statement of a material fact or omit to state a material fact necessary
         to make the  statements made, in light of the circumstances under which
         such statements  were  made,  not misleading with respect to the period
         covered by this report;

3.       Based on my knowledge, the financial  statements,  and other  financial
         information included in this report, fairly  present  in  all  material
         respects the financial condition,  results of operations and cash flows
         of the small business issuer as of,  and for,  the periods presented in
         this report;

4.       The  small  business  issuer's  other  certifying  officer  and  I  are
         responsible for establishing and maintaining  disclosure  controls  and
         procedures (as defined in Exchange  Act  Rules 13a-15(e) and 15d-15(e))
         for the small business issuer and have:

         (a)      Designed such disclosure controls and  procedures,  or  caused
                  such disclosure controls and procedures to be  designed  under
                  our supervision, to ensure that material information  relating
                  to  the  small  business  issuer,  including  its consolidated
                  subsidiaries,  is  made  known  to  us  by others within those
                  entities,  particularly   during  the  period  in  which  this
                  quarterly report is being prepared;

         (b)      Evaluated  the  effectiveness  of  the small business issuer's
                  disclosure controls  and  procedures  and  presented  in  this
                  report   our   conclusions  about  the  effectiveness  of  the
                  disclosure  controls  and  procedures,  as  of  the end of the
                  period covered by this report based on such evaluation; and

         (c)      Disclosed  in  this  report  any  change in the small business
                  issuer's  internal  control  over  financial  reporting   that
                  occurred during the small business issuer's most recent fiscal
                  quarter (the small business issuer's fourth fiscal quarter  in
                  the case of an annual report) that has materially affected, or
                  is reasonably likely to material affect,  the  small  business
                  issuer's internal control over financial reporting: and

5.       The  small  business  issuer's  other  certifying  officer  and I  have
         disclosed, based on our most recent evaluation of internal control over
         financial reporting, to the small business issuer's  auditors  and  the
         audit committee of the small business issuer's board  of  directors (or
         persons performing the equivalent functions):

         (a)      All  significant  deficiencies  and material weaknesses in the
                  design  or  operation  of  internal   control  over  financial
                  reporting which are reasonably likely to  adversely affect the
                  small business issuer's ability to record, process,  summarize
                  and report financial information; and

         (b)      Any fraud, whether or not material, that  involves  management
                  or other employees who have a  significant  role  in the small
                  business issuer's internal control over  financial  reporting.

November 14, 2007


/s/ NEIL MARTUCCI
---------------------------------
Neil Martucci
Chief Financial Officer

                                       10